Electromed (ELMD) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.32% |
| Dec 31, 2025 | -3.27% |
| Sep 30, 2025 | -4.84% |
| Jun 30, 2025 | -7.85% |
| Mar 31, 2025 | -8.93% |
| Dec 31, 2024 | -12.01% |
| Sep 30, 2024 | -11.53% |
| Jun 30, 2024 | -15.54% |
| Mar 31, 2024 | -9.22% |
| Dec 31, 2023 | -7.67% |
| Sep 30, 2023 | 1.94% |
| Jun 30, 2023 | 0.23% |
| Mar 31, 2023 | 0.83% |
| Dec 31, 2022 | -0.20% |
| Sep 30, 2022 | -0.72% |
| Jun 30, 2022 | -7.90% |
| Mar 31, 2022 | -12.75% |
| Dec 31, 2021 | -16.78% |
| Sep 30, 2021 | -23.49% |
| Jun 30, 2021 | -18.34% |
| Mar 31, 2021 | -20.43% |
| Dec 31, 2020 | -20.99% |
| Sep 30, 2020 | -24.12% |
| Jun 30, 2020 | -23.84% |
| Mar 31, 2020 | -27.88% |
| Dec 31, 2019 | -30.29% |
| Sep 30, 2019 | -28.65% |
| Jun 30, 2019 | -39.04% |
| Mar 31, 2019 | -57.71% |
| Dec 31, 2018 | -42.28% |
| Sep 30, 2018 | -48.37% |
| Jun 30, 2018 | -71.43% |
| Mar 31, 2018 | -69.49% |
| Dec 31, 2017 | -46.73% |
| Sep 30, 2017 | -31.31% |
| Jun 30, 2017 | -26.77% |
| Mar 31, 2017 | -31.14% |
| Dec 31, 2016 | -22.53% |
| Sep 30, 2016 | -5.35% |
| Jun 30, 2016 | -4.60% |
| Mar 31, 2016 | -4.54% |
| Dec 31, 2015 | 2.58% |
| Sep 30, 2015 | 8.86% |